EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Antibacterial Activity of Eravacycline Against Carbapenem-Resistant Gram-Negative Isolates in China: An in vitro Study

Xuehan Zou iD, Shaojun Jin, Lingxia Chen, Jie Li, Xiaofan Zhang, Hua Zhou iD, Xi Li iD, Haijun Huang

Infection and Drug Resistance · 2023-04 · Volume 16 · 2271-2279

DOI: 10.2147/idr.s396910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Drug Resistance, 2023-04. Verfasst von Xuehan Zou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for General Practice Medicine, Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzho…. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Eravacycline is a novel, fully synthetic fluorocycline antibiotic being developed for the treatment of serious infections, with a broad-spectrum antimicrobial activity, including against carbapenem-resistant gram-negative bacteria (CRGNB). However, the in vitro activity of eravacycline against CRGNB has not been well known in China. In this study, we analysed the antibacterial activity of eravacycline against CRGNB isolates in order to provide a theoretical basis for the clinical treatment.

Methods

A total of 346 isolates of CRGNB were collected from two different tertiary care hospitals in Zhejiang, China. Carbapenem resistance genes of all isolates were detected by polymerase chain reaction. And we analysed the in vitro activity of eravacycline against CRGNB by antimicrobial susceptibility tests. In addition, the time-kill curves were generated to evaluate the antibacterial effect of tigecycline and eravacycline.

Results

Four different types of carbapenem-resistant isolates were collected, including 50 Escherichia coli isolates, 160 Klebsiella pneumoniae isolates, 42 Enterobacter cloacae complex isolates, and 94 Acinetobacter baumannii isolates. The carbapenem resistance genes were identified in 346 isolates, including bla KPC-2 (48.0%), bla OXA-23 (27.2%), bla NDM-1 (23.1%), and bla NDM-16 (0.3%). The antimicrobial susceptibility testing results showed that the minimum inhibitory concentration (MIC) values of 346 isolates were within the sensitivity range (≤0.0625~16 mg/L) and that the MIC50 or MIC90 of eravacycline was generally approximately 2-fold lower than tigecycline. In addition, the time-kill curves showed that the bactericidal effect of eravacycline was stronger than that of tigecycline against four different types of isolates.

Conclusion

Our research indicated that eravacycline had a good antibacterial effect on CRGNB, which could provide a theoretical basis for the clinical treatment of drug-resistant bacterial infections in the future.

Schlagwörter

Stichwörter der Autor:innen

carbapenem-resistantdrug sensitivityeravacyclinegram-negative isolatestigecyclinetime-kill curves

Autor:innen und Institutionen

  • Center for General Practice Medicine, Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
  • Department of Emergency, Zhuji People's Hospital of Zhejiang Province, Shaoxing, Zhejiang, People's Republic of China.
  • Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
  • Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.

ORCID-Profile: Xuehan Zou, Hua Zhou, Xi Li

Zitieren

APA

Zou, X., Jin, S., Chen, L., Li, J., Zhang, X., Zhou, H., Li, X., & Huang, H. (2023). Antibacterial Activity of Eravacycline Against Carbapenem-Resistant Gram-Negative Isolates in China: An in vitro Study. Infection and Drug Resistance, Volume 16, 2271-2279. https://doi.org/10.2147/idr.s396910

Vancouver

Zou X, Jin S, Chen L, Li J, Zhang X, Zhou H, et al. Antibacterial Activity of Eravacycline Against Carbapenem-Resistant Gram-Negative Isolates in China: An in vitro Study. Infection and Drug Resistance. 2023;Volume 16:2271-2279. doi:10.2147/idr.s396910

BibTeX
@article{Zou2023,
  author = {Zou, Xuehan and Jin, Shaojun and Chen, Lingxia and Li, Jie and Zhang, Xiaofan and Zhou, Hua and Li, Xi and Huang, Haijun},
  title = {Antibacterial Activity of Eravacycline Against Carbapenem-Resistant Gram-Negative Isolates in China: An in vitro Study},
  journal = {Infection and Drug Resistance},
  year = {2023},
  volume = {Volume 16},
  pages = {2271--2279},
  doi = {10.2147/idr.s396910}
}
Kostenlos starten →